Press Release Bright Horizons Family Solutions Reports Fourth Quarter and Full Year 2023 Financial Results 13 February 2024
Press Release Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update 13 February 2024
Press Release Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) 13 February 2024
Press Release ChargePoint to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2024 13 February 2024
Press Release Invitation Homes Reports Fourth Quarter 2023 and Full Year 2023 Results 13 February 2024
Press Release Qurate Retail, Inc. Declares Quarterly Cash Dividend on 8.0% Series A Cumulative Redeemable Preferred Stock 13 February 2024
